FI972660A - Piperazine-2,5-dione derivatives as multidrug resistance modulators - Google Patents

Piperazine-2,5-dione derivatives as multidrug resistance modulators Download PDF

Info

Publication number
FI972660A
FI972660A FI972660A FI972660A FI972660A FI 972660 A FI972660 A FI 972660A FI 972660 A FI972660 A FI 972660A FI 972660 A FI972660 A FI 972660A FI 972660 A FI972660 A FI 972660A
Authority
FI
Finland
Prior art keywords
piperazine
multidrug resistance
dione derivatives
resistance modulators
modulators
Prior art date
Application number
FI972660A
Other languages
Finnish (fi)
Swedish (sv)
Other versions
FI972660A0 (en
Inventor
Philip Anthony Ashworth
Sukhjit Hunjan
Ian Andrew Pretswell
Hamish Ryder
Stephen James Brocchini
Original Assignee
Xenova Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Xenova Ltd filed Critical Xenova Ltd
Publication of FI972660A0 publication Critical patent/FI972660A0/en
Publication of FI972660A publication Critical patent/FI972660A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/02Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
    • C07D217/04Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FI972660A 1994-12-23 1997-06-19 Piperazine-2,5-dione derivatives as multidrug resistance modulators FI972660A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9426224.3A GB9426224D0 (en) 1994-12-23 1994-12-23 Pharmaceutical compounds
PCT/GB1995/003027 WO1996020190A1 (en) 1994-12-23 1995-12-22 Piperazine 2,5 dione derivatives as modulators of multi-drug resistance

Publications (2)

Publication Number Publication Date
FI972660A0 FI972660A0 (en) 1997-06-19
FI972660A true FI972660A (en) 1997-08-22

Family

ID=10766589

Family Applications (1)

Application Number Title Priority Date Filing Date
FI972660A FI972660A (en) 1994-12-23 1997-06-19 Piperazine-2,5-dione derivatives as multidrug resistance modulators

Country Status (19)

Country Link
EP (1) EP0799222A1 (en)
JP (1) JPH10511384A (en)
CN (1) CN1175253A (en)
AU (1) AU698828B2 (en)
BG (1) BG101602A (en)
BR (1) BR9510410A (en)
CA (1) CA2207500A1 (en)
CZ (1) CZ190097A3 (en)
FI (1) FI972660A (en)
GB (1) GB9426224D0 (en)
HU (1) HUT77943A (en)
IL (1) IL116525A0 (en)
NO (1) NO972937D0 (en)
NZ (1) NZ297847A (en)
PL (1) PL320916A1 (en)
SK (1) SK83697A3 (en)
TW (1) TW358094B (en)
WO (1) WO1996020190A1 (en)
ZA (1) ZA9510909B (en)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100354265C (en) * 1996-10-18 2007-12-12 埃克森诺瓦有限公司 Pharmaceutical compounds
GB9717576D0 (en) * 1997-08-19 1997-10-22 Xenova Ltd Pharmaceutical compounds
GB9708805D0 (en) 1997-05-01 1997-06-25 Smithkline Beecham Plc Compounds
GB9810876D0 (en) 1998-05-20 1998-07-22 Smithkline Beecham Plc Compounds
ES2255311T3 (en) 1998-10-08 2006-06-16 Smithkline Beecham Plc USEFUL TETRAHYDROBENZAZEPIN DERIVATIVES AS MODULATORS OF D3 DOPAMINE RECEPTORS (ANTI-PSYCHOTIC AGENTS).
IL150430A0 (en) * 2000-01-18 2002-12-01 Nereus Pharmaceuticals Inc Cell division inhibitors and process for producing the same
US6693099B2 (en) 2000-10-17 2004-02-17 The Procter & Gamble Company Substituted piperazine compounds optionally containing a quinolyl moiety for treating multidrug resistance
US7919497B2 (en) 2002-08-02 2011-04-05 Nereus Pharmaceuticals, Inc. Analogs of dehydrophenylahistins and their therapeutic use
US7935704B2 (en) 2003-08-01 2011-05-03 Nereus Pharmaceuticals, Inc. Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereof
ES2295695T3 (en) 2002-08-02 2008-04-16 Nereus Pharmaceuticals, Inc. DEHYDROPHENYLHYSINAS AND ITS ANALOGS AND THE SYNTHESIS OF DEHYDROPHENYLHYTHINES AND THEIR ANALOGS.
US8129527B2 (en) 2006-11-03 2012-03-06 Nereus Pharmacuticals, Inc. Analogs of dehydrophenylahistins and their therapeutic use
CN103396372B (en) * 2013-08-09 2015-05-20 中国科学院南海海洋研究所 2,5-diketopiperazine derivative, as well as preparation method and application thereof in preparing control agent for resisting marine fouling organisms
MX2017011374A (en) 2015-03-06 2018-01-23 Beyondspring Pharmaceuticals Inc Method of treating cancer associated with a ras mutation.
WO2016144636A1 (en) 2015-03-06 2016-09-15 Beyondspring Pharmaceuticals, Inc. Method of treating a brain tumor
CN109516981B (en) 2015-07-13 2019-10-22 大连万春布林医药有限公司 Pune's cloth woods composition
KR20180105685A (en) 2016-02-08 2018-09-28 비욘드스프링 파마수티컬스, 인코포레이티드. Composition containing tucaresol or analog thereof
KR20190015361A (en) 2016-06-06 2019-02-13 비욘드스프링 파마수티컬스, 인코포레이티드. Compositions and methods for reducing neutropenia
JP2020503363A (en) 2017-01-06 2020-01-30 ビヨンドスプリング ファーマシューティカルズ,インコーポレイテッド Tubulin binding compounds and their therapeutic use
CA3052190A1 (en) 2017-02-01 2018-08-09 Beyondspring Pharmaceuticals, Inc. Method of reducing neutropenia
CA3089226A1 (en) 2018-01-24 2019-08-01 Beyondspring Pharmaceuticals, Inc. Composition and method for reducing thrombocytopenia via the administration of plinabulin

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994001408A1 (en) * 1992-07-10 1994-01-20 Laboratoires Glaxo S.A. Anilide derivatives
GB9217331D0 (en) * 1992-08-14 1992-09-30 Xenova Ltd Pharmaceutical compounds

Also Published As

Publication number Publication date
CZ190097A3 (en) 1998-01-14
CN1175253A (en) 1998-03-04
BR9510410A (en) 1999-09-08
PL320916A1 (en) 1997-11-10
CA2207500A1 (en) 1996-07-04
NZ297847A (en) 1999-04-29
GB9426224D0 (en) 1995-02-22
NO972937L (en) 1997-06-23
WO1996020190A1 (en) 1996-07-04
AU698828B2 (en) 1998-11-05
EP0799222A1 (en) 1997-10-08
HUT77943A (en) 1998-12-28
TW358094B (en) 1999-05-11
AU4310096A (en) 1996-07-19
SK83697A3 (en) 1998-05-06
JPH10511384A (en) 1998-11-04
ZA9510909B (en) 1996-08-30
BG101602A (en) 1998-02-27
FI972660A0 (en) 1997-06-19
NO972937D0 (en) 1997-06-23
IL116525A0 (en) 1996-03-31

Similar Documents

Publication Publication Date Title
FI972660A0 (en) Piperazine-2,5-dione derivatives as multidrug resistance modulators
NO991563L (en) N-substituted azaheterocyclic compounds
IS4963A (en) Set 6.5-hetero-bicyclic derivatives
ATE264327T1 (en) SUBSTITUTED 6,6-HETEROBICYCLIC DERIVATIVES
DE69809755T2 (en) SUBSTITUTED 1,2,3,4-TETRAHYDRONAPHTHALINE DERIVATIVES
DE69508180T2 (en) Hot-melt inkjet composition
PT922050E (en) 3-DESCLADINOSE-2,3-ANYDROERITROMYCIN DERIVATIVES
NO982124L (en) Condensed imidazole derivatives as multidrug resistance modulators
FR2722181B1 (en) FOLDER.
NL1013652A1 (en) Piperazinone derivatives.
NO995491D0 (en) Polyolefin containing polyetheramine modified functionalized polyolefin
AU4310196A (en) Piperazine-2,5-dione derivatives as modulators of multi-drug resistance
NO20015397L (en) 1,5-Benzodiazepine derivatives
FI972885A0 (en) Anordning Foer utfoering av en divisionoperation, saerskilt i en tredimensionell grafik
ITTO940791A0 (en) ADHESIVE COMPOSITION.
DE29703051U1 (en) Offer folder
ES1033728Y (en) PERFECTED FOLDING BAG.
ES1034386Y (en) PERFECTED FOLDING SHOE.
GB2310854B (en) Piperazine-2,5-dione derivatives as modulators of multi-drug resistance
TR199600665A2 (en) Asymmetric triphenylenedioxazine compounds.
DE29808234U1 (en) Presentation folder, special application folder
ES1037001Y (en) PERFECTED FOLDER.
ES1037110Y (en) PERFECTED PACKING MACHINE.
ES1034154Y (en) PERFECTED FOLDER.
GB9815066D0 (en) Piperazine 2, 5-dione derivatives as modulators of multidrug resistance